Top Markets
#1 DogBull DogBull +53.56%
#2 OriginTrail OriginTrail +15.03%
#3 Tutorial Tutorial +11.55%
#4 Verus Coin Verus Coin +11.28%
#5 Siren Siren +11.24%
#6 龙虾 (Lobster) 龙虾 (Lobster) +9.65%
#7 Yield Basis Yield Basis +7.78%
#8 Stargate Finance Stargate Finance +7.29%
#9 Falcon Finance Falcon Finance +7.21%
#10 COTI COTI +7.12%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Macrogen, Inc. Macrogen, Inc.

Macrogen, Inc.

038290
Rank in Stocks #22135
Macrogen, Inc. specializes in offering a wide array of services within genetic... Macrogen, Inc. specializes in offering a wide array of services within genetic research and biotechnology. Their core offerings span various solutions, including whole-genome, clinical, and personalized DNA sequencing, as well as oligonucleotide synthesis, microarray analysis, and the creation of genetically engineered mice. This company was established on June 5, 1997, and its corporate headquarters are situated in Seoul, South Korea.
Share Price
$8.64
Last synced: 2026-08-21
Market Cap
$93.71M
Change (1 day)
-3.25%
Change (1 year)
-22.66%
Country
KR
Trade Macrogen, Inc. (038290)

Category

Healthcare
P/E ratio for Macrogen, Inc. (038290)
P/E ratio as of 2026 TTM: 0
According to Macrogen, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Macrogen, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.